CFLAR and colorectal cancer: Notably, a significant inverse correlation was observed between expression of FLIP(L) and sensitivity to MEDI3039 (Spearman r = −0.643; P = 0.027; Fig. 3B; Supplementary Fig. S3C); although, no significant association was observed in colorectal cancer between FLIP (CFLAR) mRNA expression and sensitivity to MEDI3039 (Supplementary Fig. S3D).